申请人:SPRINGTIDE VENTURES S.R.O.
公开号:US11014949B2
公开(公告)日:2021-05-25
The present invention relates to compounds of general formula (I) in particular for use in the treatment of senescence-related diseases, such as idiopathic pulmonary fibrosis, sarcopenia, diabetes, obesity, osteoarthritis, chronic inflammations, glaucoma, cataracts, radiation-induced oral mucosis, renal transplantation, prostatic hyperplasia.
本发明涉及通式(I)化合物,特别是用于治疗与衰老有关的疾病,如特发性肺纤维化、肌肉疏松症、糖尿病、肥胖症、骨关节炎、慢性炎症、青光眼、白内障、辐射引起的口腔粘膜病、肾移植、前列腺增生等。